Amicus Therapeutics Inc

NASDAQ:FOLD   3:59:56 PM EDT
10.52
0.00 (0.00%)
Products

U.S. FDA Accepts Filings For Amicus' AT-GAA For Treatment Of Pompe Disease

Published: 09/29/2021 11:30 GMT
Amicus Therapeutics Inc (FOLD) - U.S. FDA Accepts Filings for Amicus’ At-gaa for the Treatment of Pompe Disease.
Amicus Therapeutics - FDA Sets PDUFA Target Action Date of May 29, 2022 for New Drug Application and July 29, 2022 for Biologics License Application.
Amicus Therapeutics Inc - on Track for Maa Submission in Q4 of This Year.